source
- Ending federally funded animal testing could stall xenotransplantation breakthroughsTransplant surgeon Joshua Mezrich argues that recent moves to end federally funded animal testing could impede the development of xenotransplantation, a field that aims to use pig organs for human…
- GSK to acquire cancer-focused biotech Nuvalent for $10.6 billionGSK announced it will acquire Nuvalent, a biotech that develops targeted cancer therapies, in a transaction valued at $10.6 billion. The purchase price translates to $124 per Nuvalent share, a 26%…